Skip to main content
EVGN
NASDAQ Life Sciences

Evogene Reports 86% Q1 Revenue Plunge, $5.87M Net Loss; Raises Capital via Warrants

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.72
Mkt Cap
$8.713M
52W Low
$0.683
52W High
$2.42
52W Position info
5.4% above low
Off High info
70% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

EVGN is trading near its 52-week low of $0.683 (5.4% above the low).

Summary

Evogene reported a Q1 GAAP net loss of $5.87 million and revenue of $0.334 million, representing an 86% year-over-year decline. This follows the Q4 and full-year 2025 results reported in March, which showed a 37% reduction in annual operating expenses. The massive revenue drop and substantial net loss are highly concerning for a company with a small market capitalization, indicating severe operational challenges. The company also raised capital via warrants, which provides funding but could be dilutive.

At the time of this announcement, EVGN was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.7M. The 52-week trading range was $0.68 to $2.42. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 19, 2026, 7:12 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.3233
Real-time Price: $0.313 info
Change: -$0.0103 (-3%) info
Market Cap: $5.708M info
EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.313 info
Change: -$0.0516 (-14%) info
Market Cap: $5.708M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.313 info
Change: -$0.0971 (-24%) info
Market Cap: $5.708M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.313 info
Change: -$0.1038 (-25%) info
Market Cap: $5.708M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.313 info
Change: -$0.0777 (-20%) info
Market Cap: $5.708M info